Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural...

J Zhang, Z Chen, Q Chen - Molecules, 2024 - mdpi.com

In recent years, the frequency of strokes has been on the rise year by year and has become
the second leading cause of death around the world, which is characterized by a high …

DL-3-n-Butylphthalide Ameliorates Post-stroke Emotional Disorders by Suppressing Neuroinflammation and PANoptosis

Y Cui, Z Hu, L Wang, B Zhu, L Deng, H Zhang… - Neurochemical …, 2024 - Springer

Post-stroke emotional disorders such as post-stroke anxiety and post-stroke depression are
typical symptoms in patients with stroke. They are closely associated with poor prognosis …

MiR-122 overexpression alleviates oxygen–glucose deprivation-induced neuronal injury by targeting sPLA2-IIA

Y Yu, P Li, M Chen, W Zhan, T Zhu, L Min, H Liu… - Frontiers in …, 2024 - frontiersin.org

Background Ischemic stroke (IS) is a neurological disease with significant disability and
mortality. MicroRNAs were proven to be associated with cerebral ischemia. Previous studies …

Esculentoside H reduces the PANoptosis and protects the blood-brain barrier after cerebral ischemia/reperfusion through the TLE1/PI3K/AKT signaling pathway

K Zhang, Z Wang, H Sun, H Long, Y Wang - Experimental Neurology, 2024 - Elsevier

Abstract Aims Matrix metalloproteinases 9 (MMP9) plays a role in the destruction of blood–
brain barrier (BBB) and cell death after cerebral ischemic/reperfusion (I/R). Esculentoside H …

[HTML][HTML] Improving Long-Term Functional Outcomes of Ischemic Stroke in the Reperfusion Era

C Wu, X Chu, Z Zhu, D Wu, X Ji - Engineering, 2024 - Elsevier

Stroke remains the second leading cause of death and the third leading cause of death and
disability combined worldwide, as indicated by disability-adjusted life-years (DALYs) lost [1] …